Federated Hermes’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-566
Closed -$1K 2383
2021
Q1
$1K Sell
566
-845
-60% -$2.4K ﹤0.01% 2204
2020
Q4
$3K Buy
+1,411
New +$2.77K ﹤0.01% 2114

Other funds holding ETTX

Federated Hermes's ETTX Position: Q2 2021 in Review

Federated Hermes sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q2 2021, closing a stake of 566 shares — an estimated $1K sold.

Federated Hermes first reported a position in ETTX in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q4 2020. 24 funds tracked by Wall St. Rank hold ETTX as of Q2 2021.

  • Federated Hermes reported no remaining Entasis Therapeutics Holdings Inc. position as of Q2 2021 after selling out during the quarter.
  • Federated Hermes sold 566 Entasis Therapeutics Holdings Inc. shares in Q2 2021, an estimated $1K.
  • Federated Hermes first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2020 and held it in 2 quarters.
  • Federated Hermes's Entasis Therapeutics Holdings Inc. position peaked at $3K in Q4 2020.
  • 24 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.